MedTrace Logo

Juvederm Ultra With Lidocaine Compared With Restylane for the Correction of Nasolabial Folds

NCT00850889 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2019-01-09

Study results available
· View outcomes & findings →

Summary

Comparison of the safety and effectiveness of Juvederm Ultra with lidocaine compared with Restylane in the correction of nasolabial folds.

Conditions

  • Nasolabial Folds

Interventions

DEVICE

Hyaluronic acid gel (24 mg/mL) with 0.3% lidocaine

Day 0, maximum total volume (dosage) allowed for each NLF is 1.6 mL

DEVICE

A gel of hyaluronic acid (concentration of 20 mg/mL)

Day 0, maximum total volume (dosage) allowed for each NLF is 1.6 mL

Sponsors & Collaborators

  • Allergan Medical

    lead INDUSTRY

Principal Investigators

  • Medical Director · Allergan

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2008-11-30
Completion
2008-11-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00850889 on ClinicalTrials.gov